We exist to improve the lives
of everyone affected by epilepsy


Pfizer and Flynn Pharma fined a record £90 million for ‘excessive and unfair’ price hikes for phenytoin

7 December, 2016

Pharmaceuticals company Pfizer, which manufactures the epilepsy medicine phenytoin sodium capsules, has been fined a record £84.2 million by the Competition and Markets Authority (CMA). The company has been found to be breaking competition law by charging what the CMA said were 'excessive and unfair' prices in the UK for the medicine.